Literature DB >> 2400044

Are women using postmenopausal estrogens? A community survey.

R B Harris1, A Laws, V M Reddy, A King, W L Haskell.   

Abstract

Self-reported estrogen and progestin use in a California community was determined in 1986-87 from a telephone survey of postmenopausal women (n = 954) ages 50-65 years. Current use of hormones was reported by 32 percent; 26 percent took estrogens alone while 6 percent used estrogen + progestin. Comparisons pointed to significant social network and medical care utilization differences. Women who used estrogen therapy were younger, thinner, lived in smaller household units, and were less likely to be widowed.

Entities:  

Mesh:

Year:  1990        PMID: 2400044      PMCID: PMC1404801          DOI: 10.2105/ajph.80.10.1266

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  28 in total

1.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.

Authors:  D D Bradley; J Wingerd; D B Petitti; R M Krauss; S Ramcharan
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

2.  Estrogen plus progestin in postmenopausal women--act II.

Authors:  P C MacDonald
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

3.  Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.

Authors:  J Jensen; L Nilas; C Christiansen
Journal:  Br J Obstet Gynaecol       Date:  1986-06

4.  Epidemiology of exogenous estrogens.

Authors:  R E Markush; S L Turner
Journal:  HSMHA Health Rep       Date:  1971-01

5.  Estrogen treatment of postmenopausal women. Benefits and risks.

Authors:  E S Shoemaker; J P Forney; P C MacDonald
Journal:  JAMA       Date:  1977-10-03       Impact factor: 56.272

6.  Postmenopausal estrogen use and coronary atherosclerosis.

Authors:  J M Sullivan; R Vander Zwaag; G F Lemp; J P Hughes; V Maddock; F W Kroetz; K B Ramanathan; D M Mirvis
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

7.  Coronary risk and estrogen use in postmenopausal women.

Authors:  R I Pfeffer; G H Whipple; T T Kurosaki; J M Chapman
Journal:  Am J Epidemiol       Date:  1978-06       Impact factor: 4.897

8.  Myocardial infarction and estrogen therapy in post-menopausal women.

Authors:  L Rosenberg; B Armstrong; H Jick
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

9.  Marital status, living arrangements, and the use of health services by elderly persons.

Authors:  G L Cafferata
Journal:  J Gerontol       Date:  1987-11

10.  Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women.

Authors:  M J Tikkanen; E A Nikkila; E Vartiainen
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

View more
  11 in total

1.  Hormone replacement therapy: knowledge, attitudes, and well-being among middle-aged Australian women.

Authors:  K France; C Lee; M Schofield
Journal:  Int J Behav Med       Date:  1996

Review 2.  The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties.

Authors:  L R Chadwick; G F Pauli; N R Farnsworth
Journal:  Phytomedicine       Date:  2005-07-01       Impact factor: 5.340

3.  Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort.

Authors:  S Mohammed-Cherif; S Briançon; G Potier de Courcy; P Preziosi; B Fieux; M Zarebska; P Galan; S Hercberg
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

4.  Characteristics of women currently using hormone replacement therapy in rural areas of Styria, Austria.

Authors:  E Rásky; W Freidl; W J Stronegger; C Scheuringer
Journal:  Soz Praventivmed       Date:  1997

5.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

6.  Utilisation of hormone replacement therapy by women doctors.

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  BMJ       Date:  1995-11-25

Review 7.  Can vigorous exercise play a role in osteoporosis prevention? A review.

Authors:  B Gutin; M J Kasper
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

8.  Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.

Authors:  V Ringa; B Ledésert; G Bréart
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

9.  [Factors influencing the adoption of hormone replacement therapy].

Authors:  F Légaré; S Dodin; G Godin
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

10.  Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Authors:  C Schairer; C Byrne; P M Keyl; L A Brinton; S R Sturgeon; R N Hoover
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.